Contributors

The exhibit has been developed by:

The development would not have been possible without the kind support of:

	The Wellcome Trust is the largest charity in the UK. It funds innovative biomedical research, in the UK and internationally, spending around £600 million each year to support the brightest scientists with the best ideas. The Wellcome Trust also supports public debate about biomedical research and its impact on health and wellbeing.
	The Scottish Government is responsible for most of the issues of day-to-day concern to the people of Scotland, including health, education, justice, rural affairs, and transport. The Office of the Chief Scientific Adviser runs a science engagement grants scheme, designed to get the public more involved and interested in science. This exhibit has been one of the selected projects to inspire the public about science issues and opportunities.
Both the Wellcome Trust and the Scottish Government are main supporters of this exhibit.

Other contributors:

	NHS Blood and Transplant was established as a Special Health Authority in October 2005. Its remit is the provision of a reliable, efficient supply of blood, organs and associated services to the NHS.
	Roslin Cells is a not-for-profit company. Its mission is to produce research and clinical grade stem cell lines, to underpin development of private and public sector.
	Roslin Cellab is a ‘one stop’ stem cell facility. It has been established to make it easy for companies and researchers not equipped for stem cell research to conduct short, focused proof of concept stage research.
NHS Blood and Transplant, Roslin Cells and Roslin Cellab are also partners in the collaborative research project.
	The Scottish Stem Cell Network brings together scientists, clinicians, business and society to enable advances in stem cell biology to be rapidly translated to deliver new treatments for degenerative diseases.
	GlaxoSmithKline is a research-based pharmaceutical company. Their mission is to improve the quality of human life by enabling people to do more, feel better and live longer. They screen about 65 million compounds every year in their search for new medicines.
	Pfizer applies science and global resources to improve health and well-being at every stage of life. They strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Their diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.
	MicroVision Medical aims to improve detection, treatment and monitoring of septic patients by developing pioneering technology, evidence based development and implementing user feedback.